Sensitivity of PD-L1 analysis from pleural effusion in non-small cell lung cancer
L. Hagmeyer (Solingen, Germany), S. Herkenrath (Solingen, Germany), M. Treml (Solingen, Germany), S. Matthes (Solingen, Germany), K. Richter (Solingen, Germany), K. Hekmat (Cologne, Germany), M. Heldwein (Cologne, Germany), S. Schäfer (Cologne, Germany), R. Büttner (Cologne, Germany), M. Engels (Cologne, Germany), W. Randerath (Solingen, Germany)
Source: Virtual Congress 2020 – Novel directions in pleural disease: bench to bedside
Session: Novel directions in pleural disease: bench to bedside
Session type: E-poster session
Number: 1149
Disease area: Thoracic oncology
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Hagmeyer (Solingen, Germany), S. Herkenrath (Solingen, Germany), M. Treml (Solingen, Germany), S. Matthes (Solingen, Germany), K. Richter (Solingen, Germany), K. Hekmat (Cologne, Germany), M. Heldwein (Cologne, Germany), S. Schäfer (Cologne, Germany), R. Büttner (Cologne, Germany), M. Engels (Cologne, Germany), W. Randerath (Solingen, Germany). Sensitivity of PD-L1 analysis from pleural effusion in non-small cell lung cancer. 1149
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
High sensitivity of PD-L1 analysis from pleural effusion in nonsmall cell lung cancer Source: ERJ Open Res, 7 (1) 00787-2020; 10.1183/23120541.00787-2020 Year: 2021
Diagnostic significance of ADAM8 in non-small cell lung cancer and malignant pleural effusion Source: Annual Congress 2008 - Diagnostic aspects in thoracic oncology Year: 2008
Oncodrivers in malignant pleural effusions associated with non-small cell lung cancer Source: Virtual Congress 2020 – Interventional pulmonology: the pleura and bronchoscopic treatment of emphysema Year: 2020
Hypotonic carboplatin pleurodesis for malignant pleural effusion of non-small cell lung cancer Source: Eur Respir J 2002; 20: Suppl. 38, 273s Year: 2002
Survival of lung adenocarcinoma patients with malignant pleural effusion Source: Eur Respir J 2013; 41: 1409-1418 Year: 2013
Features of N-staging in left-sided non-small cell lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 719s Year: 2006
Evaluation of dendritic cells in peripheral blood and pleural effusion of non-small-cell lung cancer patients Source: Eur Respir J 2004; 24: Suppl. 48, 529s Year: 2004
Possibility of the specific efficacy of gefitinib for miliary lung metastasis in non-small cell lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 303s Year: 2004
Detecting extrathoracic metastases in patients with non-small cell lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 41s Year: 2006
Pleural effusions in lung cancer Source: Annual Congress 2012 - Clinical issues in malignant pleural effusions Year: 2012
Efficacy of EGFR-TKI for malignant pleural effusion in lung adenocarcinoma patients Source: International Congress 2017 – Mesothelioma and malignant pleural disease Year: 2017
PD-L1 determination in cytological and histological samples in patients with non-small cell lung cancer Source: International Congress 2018 – Linear and radial EBUS and peripheral nodules Year: 2018
Role of EBUS-TBNA in the study of PD-L1 expression in patients with non-small cell lung cancer (NSCLC) Source: Virtual Congress 2020 – Endobronchial ultrasound: from rookie to pro Year: 2020
Bronchoscopic intratumoural therapies for non-small cell lung cancer Source: Eur Respir Rev, 29 (156) 200028; 10.1183/16000617.0028-2020 Year: 2020
Visceral pleural invasion is an invasive and aggressive indicator of nonsmall cell lung cancer Source: ISSN=ISSN 1810-6838, ISBN=, page=264 Year: 2006
Biological characteristics of dendritic cells from malignant pleural effusions in patients with lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 772s Year: 2006
RNA is favourable for analysing EGFR mutations in malignant pleural effusion of lung cancer Source: Eur Respir J 2012; 39: 677-684 Year: 2012
Factors affecting the prognosis of nonsmall cell lung cancer with chest wall-parietal pleural invasion (T3) following resection Source: Annual Congress 2010 - Treatment of lung cancer Year: 2010
An update on treatment of malignant pleural effusion with or without known primary bronchial adenocarcinoma Source: Annual Congress 2006 - Medical and surgical management of malignant pleuritis Year: 2006
Ki-67 in non-small cell lung cancer Source: Annual Congress 2012 - New results in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease Year: 2012